Evidence map›Paper›PMID 36879917›Full record

ArticleBrain communications2023

Pioglitazone restores mitochondrial function but does not spare cortical tissue following mild brain contusion.

W Brad Hubbard, Hemendra J Vekaria, Olivia J Kalimon, Malinda L Spry, Emily P Brown, Todd J Kilbaugh, Patrick G Sullivan

Open access · goldAbstract read
In one paragraph

Article in Brain communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

W Brad HubbardLexington Veterans' Affairs Healthcare System, Lexington, KY 40502, USA.ORCID https://orcid.org/0000-0001-7018-0148
Hemendra J VekariaSpinal Cord and Brain Injury Research Center, University of Kentucky, Lexington, KY 40536, USA.
Olivia J KalimonSpinal Cord and Brain Injury Research Center, University of Kentucky, Lexington, KY 40536, USA.
Malinda L SprySpinal Cord and Brain Injury Research Center, University of Kentucky, Lexington, KY 40536, USA.
Emily P BrownSpinal Cord and Brain Injury Research Center, University of Kentucky, Lexington, KY 40536, USA.
Todd J KilbaughDepartment of Anesthesiology and Critical Care Medicine, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.ORCID https://orcid.org/0000-0002-4959-3092
Patrick G SullivanLexington Veterans' Affairs Healthcare System, Lexington, KY 40502, USA.ORCID https://orcid.org/0000-0001-7418-4760
University of Kentucky · USChildren's Hospital of Philadelphia · US

Funding

University of Kentucky Markey Cancer Center Support Grant ECIA SupplementP30CA177558 · NCI · UNIVERSITY OF KENTUCKY · PI KATHLEEN L. O'CONNOR · 2013 to 2026
$38.3M
Mitochondrial Uncoupling Prodrug as a Translational Therapy for TBIR01NS112693 · NINDS · UNIVERSITY OF KENTUCKY · PI KILBAUGH, TODD JUSTEN, SULLIVAN, PATRICK G · 2020 to 2025
$3.3M
Targeting mitostasis via activation of mitochondrial biogenesis after TBII01BX003405 · VA · VA MEDICAL CENTER - LEXINGTON, KY · PI SULLIVAN, PATRICK G · 2017 to 2025
–
Psychological deficits after low level blast exposure: role of neurovascular disruptionIK2BX004618 · VA · VA MEDICAL CENTER - LEXINGTON, KY · PI HUBBARD, WILLIAM BRAD · 2020 to 2024
–
BLRD VA I01 BX003405BLRD VA IK2 BX004618NCI NIH HHS P30 CA177558NINDS NIH HHS R01 NS112693
6 · The paper itself

Abstract

Pioglitazone interacts through the mitochondrial protein mitoNEET to improve brain bioenergetics following traumatic brain injury. To provide broader evidence regarding the therapeutic effects of pioglitazone after traumatic brain injury, the current study is focused on immediate and delayed therapy in a model of mild brain contusion. To assess pioglitazone therapy on mitochondrial bioenergetics in cortex and hippocampus, we use a technique to isolate subpopulations of total, glia-enriched and synaptic mitochondria. Pioglitazone treatment was initially administered at either 0.25, 3, 12 or 24 h following mild controlled cortical impact. At 48 h post-injury, ipsilateral cortex and hippocampus were dissected and mitochondrial fractions were isolated. Maximal mitochondrial respiration injury-induced deficits were observed in total and synaptic fractions, and 0.25 h pioglitazone treatment following mild controlled cortical impact was able to restore respiration to sham levels. While there are no injury-induced deficits in hippocampal fractions, we do find that 3 h pioglitazone treatment after mild controlled cortical impact can significantly increase maximal mitochondrial bioenergetics compared to vehicle-treated mild controlled cortical impact group. However, delayed pioglitazone treatment initiated at either 3 or 24 h after mild brain contusion does not improve spared cortical tissue. We demonstrate that synaptic mitochondrial deficits following mild focal brain contusion can be restored with early initiation of pioglitazone treatment. Further investigation is needed to determine functional improvements with pioglitazone beyond that of overt cortical tissue sparing following mild contusion traumatic brain injury.

Indexed as

bioenergeticsmitoNEEToxidative stressTBItraumatic brain injury

Identifiers

PMID36879917
PMCPMC9985333
OpenAlexW4320490664

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.